ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,680.29
0.56%
Dow Jones
41,841.63
0.85%
Gold vs US Dollar
3,001.115
0.33%
Brent Oil
70.74
-0.04%
Bitcoin
84,101.42
1.88%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Fractyl Health Inc (GUTS)

  7. Fractyl Health Inc (GUTS) News

Fractyl Health (GUTS)

Fractyl Health Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GUTS
DateTimeSourceHeadlineSymbolCompany
17/03/202518:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GUTSFractyl Health Inc
13/03/202521:19Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:GUTSFractyl Health Inc
13/03/202519:57Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GUTSFractyl Health Inc
04/03/202502:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GUTSFractyl Health Inc
04/03/202502:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GUTSFractyl Health Inc
04/03/202502:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GUTSFractyl Health Inc
04/03/202501:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GUTSFractyl Health Inc
03/03/202522:24Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:GUTSFractyl Health Inc
03/03/202521:05GlobeNewswire Inc.Fractyl Health Announces Fourth Quarter and Full Year 2024 Financial Results and Business UpdatesNASDAQ:GUTSFractyl Health Inc
03/03/202521:00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:GUTSFractyl Health Inc
24/02/202512:00GlobeNewswire Inc.Fractyl Health to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Updates on March 3, 2025NASDAQ:GUTSFractyl Health Inc
03/02/202523:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GUTSFractyl Health Inc
31/01/202513:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GUTSFractyl Health Inc
31/01/202513:01GlobeNewswire Inc.Fractyl Health Announces Increased Focus on Groundbreaking Revita® Weight Maintenance and Rejuva® Pancreatic Gene Therapy Programs with Potential to Deliver Key Clinical Milestones Across Multiple Studies in 2025NASDAQ:GUTSFractyl Health Inc
30/01/202521:12Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:GUTSFractyl Health Inc
13/01/202512:00GlobeNewswire Inc.Fractyl Health Announces Positive Initial Clinical Results Demonstrating Weight Maintenance Following GLP-1 Discontinuation and Revita Procedure in First Patient of the REVEAL-1 CohortNASDAQ:GUTSFractyl Health Inc
12/12/202412:00GlobeNewswire Inc.Fractyl Health Unveils Promising Preclinical Data Demonstrating Safety and Feasibility of Local Delivery of RJVA-001 Rejuva® Smart GLP-1™ Pancreatic Gene Therapy at the World Congress Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC)NASDAQ:GUTSFractyl Health Inc
09/12/202412:00GlobeNewswire Inc.Fractyl Health to Present New Preclinical Data from its Rejuva® Single-Administration Smart GLP-1 Pancreatic Gene Therapy Platform at the World Congress Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC)NASDAQ:GUTSFractyl Health Inc
26/11/202412:00GlobeNewswire Inc.Fractyl Health to Participate in the Upcoming December ConferencesNASDAQ:GUTSFractyl Health Inc
13/11/202423:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GUTSFractyl Health Inc
12/11/202421:05GlobeNewswire Inc.Fractyl Health Reports Third Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:GUTSFractyl Health Inc
04/11/202421:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GUTSFractyl Health Inc
04/11/202421:05GlobeNewswire Inc.Fractyl Health to Present New Preclinical Data on Sustained Weight Maintenance and Blood Sugar from its Rejuva® RJVA-001 Single-Administration GLP-1 Pancreatic Gene Therapy Candidate at ObesityWeek® 2024NASDAQ:GUTSFractyl Health Inc
04/11/202412:00GlobeNewswire Inc.Fractyl Health Presented New Analysis from Pooled Data of Revita® Clinical Studies Demonstrating Durable Weight Loss Maintenance for One Year at ObesityWeek® 2024NASDAQ:GUTSFractyl Health Inc
29/10/202411:00GlobeNewswire Inc.Fractyl Health to Report Third Quarter 2024 Financial Results and Provide Business Updates on November 12, 2024NASDAQ:GUTSFractyl Health Inc
28/10/202411:00GlobeNewswire Inc.Fractyl Health to Present Compelling Weight Maintenance Data from both Revita® and Rejuva® Platforms at ObesityWeek® 2024NASDAQ:GUTSFractyl Health Inc
24/09/202411:00GlobeNewswire Inc.Fractyl Health to Present at Chardan’s 8th Annual Genetic Medicines ConferenceNASDAQ:GUTSFractyl Health Inc
03/09/202411:00GlobeNewswire Inc.Fractyl Health to Participate in Upcoming September Investor ConferencesNASDAQ:GUTSFractyl Health Inc
14/08/202420:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GUTSFractyl Health Inc
14/08/202420:05GlobeNewswire Inc.Fractyl Health Reports Second Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:GUTSFractyl Health Inc
 Showing the most relevant articles for your search:NASDAQ:GUTS

Your Recent History

NYSE
TR
Tootsie Roll Industries
LSE
0QH4
Ibsm
TG
ABR
Barrick Gold
TG
CBW
Alibaba Pictures
TG
6BF
P/f Bakkafrost
LSE
AYM
Anglesey Mining
LSE
LGEN
Legal & General
LSE
GEX
Georgina Energy
LSE
VP.
Vp
LSE
0N66
Atoss Software
LSE
0LMQ
Vanguard Msci Pacific Etf
NASDAQ
TCDA
Tricida
NYSE
HHS
Harte Hanks
USOTC
ARRT
Artisan Consumer Goods (PK)
NYSE
CSC
Computer Sciences
TSXV
SCT
Skychain Technologies
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2025 ADVFN PLC - All Rights Reserved

    Go Ad-Free

    Subscribe to Ad free and enjoy an ad-free experience

    No Ads

    Try Now

    Keep the Ads